Chronic prostatitis.

Chronic prostatitis, which is one of the most common diseases with which the adult male is afflicted [1, 2], covers a wide range of symptoms originating in the prostate. Gartman [3] collected 178 of these symptoms related to the strategic position of the prostate to the urinary, genital and gastro-intestinal tract. A classification based on histological appearance by Swinney [14] divides the clinical heterogeneous group of chronic prostatitis in a true inflammatory group, a group with no evidence of inflammatory changes and a third small group of granulomatous prostatitis first described by Tanner and McDonald [5]. A new extract Cernitin (2) was introduced in 1959 by Ask-Upmark [6] in the therapy of this syndrome. This paper gives the preliminary results in small group of patients treated with this product in combination with a study of some constituents of prostatic fluid in this disease.